Novo Nordisk A/S

(NYSE:NVO)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 871,000 975,000 977,000 584,000
Cash At End Of Period 1,328,000 1,221,000 851,000 904,000
Net Change In Cash And Cash Equivalents 455,000 247,000 -126,000 320,000
Effect Of Exchange Rate Changes -1,000 3,000 -5,000 -1,000
Net Income Or Loss 1,380,000 982,000 461,000 1,669,000
Cash From Operating Activities
Depreciation Expenses 589,000
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes
Operating Gains Or Losses -221,000 -196,000 -76,000 -251,000
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables -137,000
Increase Or Decrease In Inventories -121,000
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables
Increase Or Decrease In Other Current Liabilities 57,000
Increase Or Decrease In Other Working Capital
Other Non Cash Items -240,000 -181,000 -39,000
Net Cash From Continuing Operations 903,000 659,000 304,000 151,000
Net Cash From Discontinued Operations 1,823,000 1,264,000 650,000 1,955,000
Net Cash From Operating Activities
Cash From Investing Activities
Sale Of Property Plant And Equipment 8,000
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -233,000 -163,000 -58,000 -475,000
Acquisitions -12,000
Purchase Of Long Term Investments
Purchase Of Short Term Investments -106,000
Other Investing Changes Net 32,000 36,000 288,000
Cash From Discontinued Investing Activities
Net Cash From Investing Activities -201,000 -126,000 -57,000 -297,000
Cash From Financing Activities
Issuance Of Debt 47,000
Issuance Of Capital Stock -4,000
Repayment Of Debt -947,000
Repurchase Of Capital Stock -435,000
Payment Of Cash Dividends -1,165,000 -894,000 -713,000
Net Other Financing Charges -1,165,000 -894,000 -713,000
Cash From Discontinued Financing Activities
Net Cash From Financing Activities -1,165,000 -894,000 -713,000 -1,338,000